{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T22:50:11Z","timestamp":1789167011512,"version":"build-2803163510"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,18]],"date-time":"2024-11-18T00:00:00Z","timestamp":1731888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,18]],"date-time":"2024-11-18T00:00:00Z","timestamp":1731888000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-80089-8","type":"journal-article","created":{"date-parts":[[2024,11,18]],"date-time":"2024-11-18T15:19:13Z","timestamp":1731943153000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Formulation development, characterization, and mechanistic PBPK modeling of metoclopramide loaded halloysite nanotube (HNT) based drug-in-adhesive type transdermal drug delivery system"],"prefix":"10.1038","volume":"14","author":[{"given":"Monica","family":"Parkash","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Harris","family":"Shoaib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Sikandar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rabia Ismail","family":"Yousuf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Talha","family":"Saleem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farrukh Rafiq","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahad","family":"Siddiqui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,18]]},"reference":[{"key":"80089_CR1","doi-asserted-by":"publisher","first-page":"86","DOI":"10.7326\/0003-4819-98-1-86","volume":"98","author":"Metoclopramide","year":"1983","unstructured":"Metoclopramide pharmacology and clinical application. Ann. Intern. Med. 98, 86\u201395. (1983).","journal-title":"Ann. Intern. Med."},{"key":"80089_CR2","first-page":"213","volume":"6","author":"O Eraga","year":"2020","unstructured":"Eraga, O., Arhewoh, S. I., Meko, A. & M. & Evaluation of transdermal formulations of metoclopramide prepared using arachis oil and liquid paraffin as permeation enhancers. Pharma Biomed. Res. 6, 213\u2013222 (2020).","journal-title":"Pharma Biomed. Res."},{"key":"80089_CR3","unstructured":"Meko, O. A., Eraga, S. & Arhewoh, M. Transdermal delivery of metoclopramide using eucalyptus oil and shea butter. 12, 208\u2013216 (2020)."},{"key":"80089_CR4","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/nrd1304","volume":"3","author":"MR Prausnitz","year":"2004","unstructured":"Prausnitz, M. R., Mitragotri, S. & Langer, R. Current status and future potential of transdermal drug delivery. Nat. Rev. Drug Discov. 3, 115\u2013124 (2004).","journal-title":"Nat. Rev. Drug Discov"},{"key":"80089_CR5","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.sjbs.2021.08.088","volume":"29","author":"L Mo","year":"2022","unstructured":"Mo, L., Lu, G., Ou, X. & Ouyang, D. Formulation and development of novel control release transdermal patches of carvedilol to improve bioavailability for the treatment of heart failure. Saudi J. Biol. Sci. 29, 266\u2013272. https:\/\/doi.org\/10.1016\/j.sjbs.2021.08.088 (2022).","journal-title":"Saudi J. Biol. Sci."},{"key":"80089_CR6","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1007\/s00289-021-03559-3","volume":"79","author":"MS Imtiaz","year":"2022","unstructured":"Imtiaz, M. S. et al. Formulation development and evaluation of drug-in-adhesive-type transdermal patch of metoclopramide HCl. Polym. bull. 79, 1187\u20131200. https:\/\/doi.org\/10.1007\/s00289-021-03559-3 (2022).","journal-title":"Polym. bull."},{"key":"80089_CR7","doi-asserted-by":"publisher","first-page":"438","DOI":"10.3390\/pharmaceutics7040438","volume":"7","author":"AZ Alkilani","year":"2015","unstructured":"Alkilani, A. Z., McCrudden, M. T. & Donnelly, R. F. Transdermal drug delivery: innovative pharmaceutical developments based on disruption of the barrier properties of the stratum corneum. Pharmaceutics 7, 438\u2013470. https:\/\/doi.org\/10.3390\/pharmaceutics7040438 (2015).","journal-title":"Pharmaceutics"},{"key":"80089_CR8","doi-asserted-by":"crossref","unstructured":"Kahali, N., Khanam, J. & Ghosh, N. An attempt to enhance solubility of metoclopramide base by solid dispersion strategy and its application on development of transdermal device. Brazilian J. Pharma Sci. 57 (2021).","DOI":"10.1590\/s2175-97902020000418910"},{"key":"80089_CR9","first-page":"48","volume":"2","author":"S Amin","year":"2012","unstructured":"Amin, S., Mir, S., Kohli, K. & Ali, A. Novel polymeric matrix films for transdermal delivery of metoclopramide. Int. J. Pharma Front. Res. 2, 48\u201360 (2012).","journal-title":"Int. J. Pharma Front. Res."},{"key":"80089_CR10","first-page":"740","volume":"43","author":"M Saxena","year":"2006","unstructured":"Saxena, M., Mutalik, S. & Reddy, M. Formulation and evaluation of transdermal patches of metoclopramide hydrochloride. Indian Drugs. 43, 740\u2013745 (2006).","journal-title":"Indian Drugs"},{"key":"80089_CR11","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3810\/psm.2011.09.1923","volume":"39","author":"K Marren","year":"2011","unstructured":"Marren, K. Dimethyl sulfoxide: an effective penetration enhancer for topical administration of NSAIDs. Phys. Sportsmed. 39, 75\u201382. https:\/\/doi.org\/10.3810\/psm.2011.09.1923 (2011).","journal-title":"Phys. Sportsmed."},{"key":"80089_CR12","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/jdv.15946","volume":"33","author":"B Chuberre","year":"2019","unstructured":"Chuberre, B., Araviiskaia, E., Bieber, T. & Barbaud, A. Mineral oils and waxes in cosmetics: an overview mainly based on the current European regulations and the safety profile of these compounds. J. Europ Acad. Dermatol. Venereol. 33, 5\u201314. https:\/\/doi.org\/10.1111\/jdv.15946 (2019).","journal-title":"J. Europ Acad. Dermatol. Venereol."},{"key":"80089_CR13","first-page":"9","volume":"36","author":"P Jayvadan","year":"2016","unstructured":"Jayvadan, P. & Rupal, J. Enhancing effect of natural oils as permeation enhancer for transdermal delivery of diltiazem hydrochloride through Wistar rat skin. Int. J. Pharm. Sci. Rev. Res. 36, 9\u201316 (2016).","journal-title":"Int. J. Pharm. Sci. Rev. Res."},{"key":"80089_CR14","doi-asserted-by":"publisher","first-page":"23444","DOI":"10.1039\/D0NR06820A","volume":"12","author":"OP Setter","year":"2020","unstructured":"Setter, O. P. & Segal, E. Halloysite nanotubes\u2013the nano-bio interface. Nanoscale 12, 23444\u201323460 (2020).","journal-title":"Nanoscale"},{"key":"80089_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00604-018-2908-1","volume":"185","author":"M Fizir","year":"2018","unstructured":"Fizir, M. et al. Halloysite nanotubes in analytical sciences and in drug delivery: a review. Microchim. Acta. 185, 1\u201333 (2018).","journal-title":"Microchim. Acta"},{"key":"80089_CR16","doi-asserted-by":"publisher","first-page":"4863","DOI":"10.3390\/molecules25204863","volume":"25","author":"M Massaro","year":"2020","unstructured":"Massaro, M., Noto, R., Riela, S. & Past Present and Future perspectives on Halloysite Clay minerals. Molecules 25, 4863 (2020).","journal-title":"Molecules"},{"key":"80089_CR17","doi-asserted-by":"crossref","unstructured":"Ahmed, F. R. et al. In-vitro assessment of cytotoxicity of halloysite nanotubes against HepG2, HCT116 and human peripheral blood lymphocytes. 135, 50\u201355 (2015).","DOI":"10.1016\/j.colsurfb.2015.07.021"},{"key":"80089_CR18","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.ejps.2019.03.028","volume":"133","author":"FR Ahmed","year":"2019","unstructured":"Ahmed, F. R. et al. Clay nanotubes as a novel multifunctional excipient for the development of directly compressible diclofenac potassium tablets in a SeDeM driven QbD environment. Eur. J. Pharma Sci. 133, 214\u2013227. https:\/\/doi.org\/10.1016\/j.ejps.2019.03.028 (2019).","journal-title":"Eur. J. Pharma Sci."},{"key":"80089_CR19","first-page":"71","volume":"62","author":"K Krej\u010dov\u00e1","year":"2013","unstructured":"Krej\u010dov\u00e1, K., Deasy, P. B. & Rabi\u0161kov\u00e1, M. Optimization of diclofenac sodium profile from halloysite nanotubules. Ceska Slov. Farmacie: casopis Ceske farmaceuticke spolecnosti Slovenske farmaceuticke spolecnosti. 62, 71\u201377 (2013).","journal-title":"Ceska Slov. Farmacie: casopis Ceske farmaceuticke spolecnosti Slovenske farmaceuticke spolecnosti"},{"key":"80089_CR20","doi-asserted-by":"publisher","first-page":"4392","DOI":"10.3390\/molecules26154392","volume":"26","author":"A Borrego-S\u00e1nchez","year":"2021","unstructured":"Borrego-S\u00e1nchez, A., Sainz-D\u00edaz, C. I., Perioli, L. & Viseras, C. Theoretical study of retinol, niacinamide and glycolic acid with halloysite clay mineral as active ingredients for topical skin care formulations. Molecules (Basel Switzerland). 26, 4392. https:\/\/doi.org\/10.3390\/molecules26154392 (2021).","journal-title":"Molecules (Basel Switzerland)"},{"key":"80089_CR21","doi-asserted-by":"publisher","first-page":"3463","DOI":"10.2147\/ijn.s367540","volume":"17","author":"M Sikandar","year":"2022","unstructured":"Sikandar, M. et al. Nanoclay-based composite films for transdermal drug delivery: development, characterization, and in silico modeling and simulation. Int. J. Nanomed. 17, 3463\u20133481. https:\/\/doi.org\/10.2147\/ijn.s367540 (2022).","journal-title":"Int. J. Nanomed."},{"key":"80089_CR22","doi-asserted-by":"publisher","first-page":"e3000410","DOI":"10.1371\/journal.pbio.3000410","volume":"18","author":"Percie du Sert","year":"2020","unstructured":"Percie du Sert. The ARRIVE guidelines 2.0: updated guidelines for reporting animal research. PLOS Biol. 18, e3000410. https:\/\/doi.org\/10.1371\/journal.pbio.3000410 (2020).","journal-title":"PLOS Biol."},{"key":"80089_CR23","unstructured":"Council, N. R. Guide for the care and use of laboratory animals. (2010)."},{"key":"80089_CR24","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/S0378-5173(02)00702-0","volume":"253","author":"SR Levis","year":"2003","unstructured":"Levis, S. R. & Deasy, P. B. Use of coated microtubular halloysite for the sustained release of diltiazem hydrochloride and propranolol hydrochloride. Int. J. Pharm. 253, 145\u2013157. https:\/\/doi.org\/10.1016\/S0378-5173(02)00702-0 (2003).","journal-title":"Int. J. Pharm."},{"key":"80089_CR25","doi-asserted-by":"publisher","first-page":"197","DOI":"10.2478\/acph-2019-0016","volume":"69","author":"OA Al Hanbali","year":"2019","unstructured":"Al Hanbali, O. A. et al. Transdermal patches: design and current approaches to painless drug delivery. Acta Pharm. 69, 197\u2013215 (2019).","journal-title":"Acta Pharm."},{"key":"80089_CR26","doi-asserted-by":"publisher","first-page":"240","DOI":"10.4103\/2230-973X.93008","volume":"1","author":"P Prabhu","year":"2011","unstructured":"Prabhu, P., Shah, S. & Gundad, S. Formulation development and investigation of domperidone transdermal patches. Int. J. Pharm. Investig. 1, 240\u2013246. https:\/\/doi.org\/10.4103\/2230-973X.93008 (2011).","journal-title":"Int. J. Pharm. Investig"},{"key":"80089_CR27","first-page":"00039","volume":"3","author":"F Mohd","year":"2017","unstructured":"Mohd, F., Bontha, L., Bontha, V. & Vemula, S. Formulation and evaluation of transdermal films of ondansetron hydrochloride. MOJ Bioequiv Availab. 3, 00039 (2017).","journal-title":"MOJ Bioequiv Availab."},{"key":"80089_CR28","first-page":"774","volume":"6","author":"RS Nair","year":"2013","unstructured":"Nair, R. S., Ling, T. N., Shukkoor, M. S. A. & Manickam, B. Matrix type transdermal patches of captopril: ex vivo permeation studies through excised rat skin. J. Pharm. Res. 6, 774\u2013779 (2013).","journal-title":"J. Pharm. Res."},{"key":"80089_CR29","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1002\/jps.10200","volume":"91","author":"P Arora","year":"2002","unstructured":"Arora, P. & Mukherjee, B. Design, development, physicochemical, and in vitro and in vivo evaluation of transdermal patches containing diclofenac diethylammonium salt. J. Pharm. Sci. 91, 2076\u20132089. https:\/\/doi.org\/10.1002\/jps.10200 (2002).","journal-title":"J. Pharm. Sci."},{"key":"80089_CR30","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.ijpharm.2004.11.007","volume":"289","author":"C Amnuaikit","year":"2005","unstructured":"Amnuaikit, C., Ikeuchi, I., Ogawara, K., Higaki, K. & Kimura, T. Skin permeation of propranolol from polymeric film containing terpene enhancers for transdermal use. Int. J. Pharm. 289, 167\u2013178 (2005).","journal-title":"Int. J. Pharm."},{"key":"80089_CR31","doi-asserted-by":"publisher","first-page":"211","DOI":"10.4314\/tjpr.v14i2.4","volume":"14","author":"SRN David","year":"2015","unstructured":"David, S. R. N., Rajabalaya, R. & Zhia, E. S. Development and in vitro evaluation of self-adhesive matrix-type transdermal delivery system of ondansetron hydrochloride. Trop. J. Pharm. Res. 14, 211\u2013218 (2015).","journal-title":"Trop. J. Pharm. Res."},{"key":"80089_CR32","unstructured":"USP. (2021)."},{"key":"80089_CR33","doi-asserted-by":"publisher","first-page":"349","DOI":"10.2147\/DDDT.S147082","volume":"12","author":"MR Akram","year":"2018","unstructured":"Akram, M. R., Ahmad, M., Abrar, A., Sarfraz, R. M. & Mahmood, A. Formulation design and development of matrix diffusion controlled transdermal drug delivery of glimepiride. Drug Des. Dev. Ther. 12, 349\u2013364. https:\/\/doi.org\/10.2147\/DDDT.S147082 (2018).","journal-title":"Drug Des. Dev. Ther."},{"key":"80089_CR34","first-page":"171","volume":"3","author":"V Wamorkar","year":"2011","unstructured":"Wamorkar, V., Manjunath, S. Y. & Varma, M. Development and validation of UV spectroscopic method for determination of metoclopramide hydrochloride in bulk and tablet formulation. Int. J. Pharm. Pharm. Sci. 3, 171\u2013174 (2011).","journal-title":"Int. J. Pharm. Pharm. Sci."},{"key":"80089_CR35","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1208\/s12248-010-9185-1","volume":"12","author":"Y Zhang","year":"2010","unstructured":"Zhang, Y. et al. DDSolver: an add-in program for modeling and comparison of drug dissolution profiles. AAPS J. 12, 263\u2013271. https:\/\/doi.org\/10.1208\/s12248-010-9185-1 (2010).","journal-title":"AAPS J."},{"key":"80089_CR36","doi-asserted-by":"publisher","unstructured":"Ali, F. R. et al. Design, Development, and Optimization of Dexibuprofen Microemulsion Based Transdermal Reservoir Patches for Controlled Drug Delivery. BioMed. Res. Int. 4654958, doi: (2017). https:\/\/doi.org\/10.1155\/2017\/4654958 (2017).","DOI":"10.1155\/2017\/4654958"},{"key":"80089_CR37","unstructured":"Haney, P., Herting, K. & Smith, S. Molecular weight cut-off (MWCO) specifications and rates of buffer exchange with Slide-A-Lyzer dialysis devices and snakeskin dialysis tubing. Protein Biol. Resour. Libr. ThermoFisher Sci. Waltam (2013)."},{"key":"80089_CR38","doi-asserted-by":"publisher","first-page":"E13","DOI":"10.1208\/pt0801002","volume":"8","author":"U Ubaidulla","year":"2007","unstructured":"Ubaidulla, U., Reddy, M. V. S., Ruckmani, K., Ahmad, F. J. & Khar, R. K. Transdermal therapeutic system of carvedilol: Effect of hydrophilic and hydrophobic matrix on in vitro and in vivo characteristics. AAPS PharmSciTech. 8, E13\u2013E20. https:\/\/doi.org\/10.1208\/pt0801002 (2007).","journal-title":"AAPS PharmSciTech"},{"key":"80089_CR39","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1021\/js970161+","volume":"86","author":"JR Kunta","year":"1997","unstructured":"Kunta, J. R., Goskonda, V. R., Brotherton, H. O., Khan, M. A. & Reddy, I. K. Effect of menthol and related terpenes on the percutaneous absorption of propranolol across excised hairless mouse skin. J. Pharm. Sci. 86, 1369\u20131373. https:\/\/doi.org\/10.1021\/js970161+ (1997).","journal-title":"J. Pharm. Sci."},{"key":"80089_CR40","unstructured":"Adrian, C. Williams. in Aulton\u2019s Pharmaceutics - The design and manufacture of medicine Vol. 1 (ed Micheal F. Aulton and Kevin M. G. Taylor) Ch. 40, 715\u2013738 (Elsevier, 2018)."},{"key":"80089_CR41","first-page":"193","volume":"10","author":"P Kumar De","year":"2011","unstructured":"Kumar De, P. et al. Optimization of in - vitro permeation pattern of ketorolac tromethamine transdermal patches. Iran. J. Pharm. Res. 10, 193\u2013201 (2011).","journal-title":"Iran. J. Pharm. Res."},{"key":"80089_CR42","unstructured":"Council, N. R. Guide for the care and use of Laboratory Animals: Eighth Edition (National Academies, 2011)."},{"key":"80089_CR43","doi-asserted-by":"publisher","unstructured":"Singh, A. & Bali, A. Formulation and characterization of transdermal patches for controlled delivery of duloxetine hydrochloride. J. Anal. Sci. Technol. 7 https:\/\/doi.org\/10.1186\/s40543-016-0105-6 (2016).","DOI":"10.1186\/s40543-016-0105-6"},{"key":"80089_CR44","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1021\/mp034006h","volume":"1","author":"NA Kasim","year":"2004","unstructured":"Kasim, N. A. et al. Molecular properties of WHO essential drugs and provisional biopharmaceutical classification. Mol. Pharm. 1, 85\u201396 (2004).","journal-title":"Mol. Pharm."},{"key":"80089_CR45","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1111\/j.1365-2125.1978.tb04604.x","volume":"6","author":"D Bateman","year":"1978","unstructured":"Bateman, D., Kahn, C., Mashiter, K. & Davies, D. Pharmacokinetic and concentration-effect studies with intravenous metoclopramide. Br. J. Clin. Pharmacol. 6, 401\u2013407 (1978).","journal-title":"Br. J. Clin. Pharmacol."},{"key":"80089_CR46","doi-asserted-by":"publisher","first-page":"3700","DOI":"10.1002\/jps.21276","volume":"97","author":"A Stosik","year":"2008","unstructured":"Stosik, A. et al. Biowaiver monographs for immediate release solid oral dosage forms: Metoclopramide hydrochloride. J. Pharm. Sci. 97, 3700\u20133708 (2008).","journal-title":"J. Pharm. Sci."},{"key":"80089_CR47","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1111\/j.1365-2125.1986.tb05201.x","volume":"21","author":"D Webb","year":"1986","unstructured":"Webb, D., Buss, D., Fifield, R., Bateman, D. & Routledge, P. The plasma protein binding of metoclopramide in health and renal disease. Br. J. Clin. Pharmacol. 21, 334\u2013336 (1986).","journal-title":"Br. J. Clin. Pharmacol."},{"key":"80089_CR48","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/S0939-6411(03)00022-5","volume":"55","author":"EI Hasan","year":"2003","unstructured":"Hasan, E. I., Amro, B. I., Arafat, T. & Badwan, A. A. Assessment of a controlled release hydrophilic matrix formulation for metoclopramide HCl. Eur. J. Pharm. Biopharm. 55, 339\u2013344. https:\/\/doi.org\/10.1016\/S0939-6411(03)00022-5 (2003).","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"80089_CR49","first-page":"465","volume":"20","author":"L Ross-Lee","year":"1981","unstructured":"Ross-Lee, L., Eadie, M., Hooper, W. & Bochner, F. J. E. Single-dose pharmacokinetics of metoclopramide. J. O C P. 20, 465\u2013471 (1981).","journal-title":"J. O C P"},{"key":"80089_CR50","first-page":"21","volume":"9","author":"C Kuemmel","year":"2020","unstructured":"Kuemmel, C. et al. Consideration of a credibility assessment framework in model-informed drug development: potential application to physiologically\u2010based pharmacokinetic modeling and simulation. CPT: Pharmacometrics Syst. Pharmacol. 9, 21\u201328 (2020).","journal-title":"CPT: Pharmacometrics Syst. Pharmacol."},{"key":"80089_CR51","doi-asserted-by":"publisher","first-page":"104990","DOI":"10.1016\/j.tiv.2020.104990","volume":"69","author":"CA Ellison","year":"2020","unstructured":"Ellison, C. A. et al. Partition coefficient and diffusion coefficient determinations of 50 compounds in human intact skin, isolated skin layers and isolated stratum corneum lipids. Toxicol. Vitro. 69, 104990. https:\/\/doi.org\/10.1016\/j.tiv.2020.104990 (2020).","journal-title":"Toxicol. Vitro"},{"key":"80089_CR52","first-page":"1","volume":"current step 4","author":"Guideline","year":"2003","unstructured":"GuidelineI. H. T. Stability testing of new drug substances and products. Q1A (R2). current step 4, 1\u201324 (2003).","journal-title":"Q1A (R2)"},{"key":"80089_CR53","first-page":"151","volume":"29","author":"D Schuppan","year":"1979","unstructured":"Schuppan, D., Schmidt, I. & Heller, M. [Preliminary pharmacokinetics of metoclopramide in humans. Plasma levels following a single oral and intravenous dose (author\u2019s transl)]. Arzneimittelforschung 29, 151\u2013154 (1979).","journal-title":"Arzneimittelforschung"},{"key":"80089_CR54","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1002\/jps.20058","volume":"93","author":"S Mutalik","year":"2004","unstructured":"Mutalik, S. & Udupa, N. Glibenclamide transdermal patches: physicochemical, pharmacodynamic, and pharmacokinetic evaluations. J. Pharm. Sci. 93, 1577\u20131594. https:\/\/doi.org\/10.1002\/jps.20058 (2004).","journal-title":"J. Pharm. Sci."},{"key":"80089_CR55","first-page":"296","volume":"4","author":"KN Patel","year":"2012","unstructured":"Patel, K. N., Patel, H. K. & Patel, V. A. Formulation and characterization of drug in adhesive transdermal patches of diclofenac acid. Int. J. Pharm. Pharm. Sci. 4, 296\u2013299 (2012).","journal-title":"Int. J. Pharm. Pharm. Sci."},{"key":"80089_CR56","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.2147\/IJN.S299261","volume":"2021","author":"T Husain","year":"2021","unstructured":"Husain, T. et al. Investigating Halloysite nanotubes as a potential platform for oral modified delivery of different BCS class drugs: characterization, optimization, and evaluation of drug release kinetics. Int. J. Nanomed. 2021, 1725\u20131741. https:\/\/doi.org\/10.2147\/IJN.S299261 (2021).","journal-title":"Int. J. Nanomed."},{"key":"80089_CR57","doi-asserted-by":"publisher","first-page":"11518","DOI":"10.3390\/ijms231911518","volume":"23","author":"G Biddeci","year":"2022","unstructured":"Biddeci, G., Spinelli, G., Colomba, P., Di Blasi, F. & Nanomaterials A review about Halloysite nanotubes, properties, and application in the Biological Field. Int. J. Mol. Sci. 23, 11518 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"80089_CR58","doi-asserted-by":"publisher","unstructured":"Abdouss, M. et al. Fabrication of Bio-nanocomposite based on HNT-Methionine for controlled release of Phenytoin. Polymers 13 https:\/\/doi.org\/10.3390\/polym13152576 (2021).","DOI":"10.3390\/polym13152576"},{"key":"80089_CR59","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.ejps.2018.01.038","volume":"115","author":"D Yang","year":"2018","unstructured":"Yang, D., Wan, X., Quan, P., Liu, C. & Fang, L. The role of carboxyl group of pressure sensitive adhesive in controlled release of propranolol in transdermal patch: quantitative determination of ionic interaction and molecular mechanism characterization. Eur. J. Pharm. Sci. 115, 330\u2013338. https:\/\/doi.org\/10.1016\/j.ejps.2018.01.038 (2018).","journal-title":"Eur. J. Pharm. Sci."},{"key":"80089_CR60","doi-asserted-by":"publisher","first-page":"110527","DOI":"10.1016\/j.colsurfb.2019.110527","volume":"184","author":"S Sharif","year":"2019","unstructured":"Sharif, S. et al. Mucoadhesive micro-composites: Chitosan coated halloysite nanotubes for sustained drug delivery. Colloids Surf. B Biointerfaces. 184, 110527 (2019).","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"80089_CR61","doi-asserted-by":"publisher","first-page":"110685","DOI":"10.1016\/j.msec.2020.110685","volume":"110","author":"A Mohebali","year":"2020","unstructured":"Mohebali, A., Abdouss, M. & Afshar Taromi, F. Fabrication of biocompatible antibacterial nanowafers based on HNT\/PVA nanocomposites loaded with minocycline for burn wound dressing. Mater. Sci. Eng. C. 110, 110685. https:\/\/doi.org\/10.1016\/j.msec.2020.110685 (2020).","journal-title":"Mater. Sci. Eng. C"},{"key":"80089_CR62","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1016\/j.ijpharm.2016.08.015","volume":"511","author":"C Liu","year":"2016","unstructured":"Liu, C., Hui, M., Quan, P. & Fang, L. Drug in adhesive patch of palonosetron: effect of pressure sensitive adhesive on drug skin permeation and in vitro-in vivo correlation. Int. J. Pharm. 511, 1088\u20131097 (2016).","journal-title":"Int. J. Pharm."},{"key":"80089_CR63","first-page":"26","volume":"56","author":"R Parhi","year":"2018","unstructured":"Parhi, R. & Padilam, S. In vitro permeation and stability studies on developed drug-in-adhesive transdermal patch of simvastatin. Bull. Fac. Pharm. Cairo Univ. 56, 26\u201333 (2018).","journal-title":"Bull. Fac. Pharm. Cairo Univ."},{"key":"80089_CR64","unstructured":"Roberto D\u00edaz-Torres. in. CURRENT TECHNOLOGIES TO INCREASE THE TRANSDERMAL DELIVERY OF DRUGS Vol. 1 (ed Jos\u00e9 Juan Escobar-Ch\u00e1vez) Ch. 7, 121 (Bentham Science, 2010)."},{"key":"80089_CR65","doi-asserted-by":"crossref","unstructured":"Robinson, J. & Lee, V. H. Controlled drug Delivery: Fundamentals and Applications (CRC, 1987).","DOI":"10.1201\/b14193"},{"key":"80089_CR66","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.2147\/ijn.S299261","volume":"16","author":"T Husain","year":"2021","unstructured":"Husain, T. et al. Investigating Halloysite nanotubes as a potential platform for oral modified delivery of different BCS class drugs: characterization, optimization, and evaluation of drug release kinetics. Int. J. Nanomed. 16, 1725\u20131741. https:\/\/doi.org\/10.2147\/ijn.S299261 (2021).","journal-title":"Int. J. Nanomed."},{"key":"80089_CR67","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.3109\/10837450.2012.710240","volume":"18","author":"A Sava\u015fer","year":"2013","unstructured":"Sava\u015fer, A., Ta\u015f, \u00c7., Bayrak, Z., \u00d6zkan, C. K. & \u00d6zkan, Y. Effect of different polymers and their combinations on the release of metoclopramide HCl from sustained-release hydrophilic matrix tablets. Pharm. Dev. Technol. 18, 1122\u20131130. https:\/\/doi.org\/10.3109\/10837450.2012.710240 (2013).","journal-title":"Pharm. Dev. Technol."},{"key":"80089_CR68","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1111\/j.2042-7158.1985.tb05093.x","volume":"37","author":"AG Mitchell","year":"1985","unstructured":"Mitchell, A. G. Polymorphism in metoclopramide hydrochloride and metoclopramide. J. Pharm. Pharmacol. 37, 601\u2013604. https:\/\/doi.org\/10.1111\/j.2042-7158.1985.tb05093.x (1985).","journal-title":"J. Pharm. Pharmacol."},{"key":"80089_CR69","first-page":"383","volume":"40","author":"E Joussein","year":"2005","unstructured":"Joussein, E. et al. Halloysite clay minerals\u2014a review. J. C m. 40, 383\u2013426 (2005).","journal-title":"J. C m"},{"key":"80089_CR70","doi-asserted-by":"crossref","unstructured":"Bateman, D., Kahn, C., Mashiter, K. & Davies, D. J. B. J. o. C. P. Pharmacokinetic and concentration-effect studies with intravenous metoclopramide. 6, 401\u2013407 (1978).","DOI":"10.1111\/j.1365-2125.1978.tb04604.x"},{"key":"80089_CR71","doi-asserted-by":"crossref","unstructured":"Khalid, S., Rasool, M.F., Masood, I. et al. Application of a physiologically based pharmacokinetic model inpredicting captopril disposition in children with chronic kidney disease.  Sci. Rep. 13, 2697 (2023).","DOI":"10.1038\/s41598-023-29798-0"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-80089-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-80089-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-80089-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,18]],"date-time":"2024-11-18T16:04:18Z","timestamp":1731945858000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-80089-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,18]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["80089"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-80089-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,18]]},"assertion":[{"value":"15 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"28512"}}